VYNE Therapeutics Offloads Its Topical Minocycline Assets To Journey Medical In $450M+ Deal
January 13, 2022 at 08:38 AM EST
Journey Medical Corporation(NASDAQ: DERM) has acquired Molecule Stabilizing Technology (MST) franchise, including Amzeeq ...